key: cord-0754934-xet1kjoc authors: Miyazawa, Dr. Daisuke title: Letter in response to article in journal of infection: “Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study” date: 2020-09-28 journal: J Infect DOI: 10.1016/j.jinf.2020.09.030 sha: 388cbcee81e33891ef8e3cde0ed72874879e6034 doc_id: 754934 cord_uid: xet1kjoc nan We read with great interest the study by Ishii M et al., in which hyperuricemia was deemed a novel risk factor for COVID-related death 1 . In this study, severity was defined as the need for oxygen supplementation. Respiratory failure is indeed the most important pathology that contributes to the severity of COVID-19. Obesity is associated with restrictive breathing patterns and reduced lung volumes and is a risk factor for acute respiratory distress syndrome 2 . Furthermore, it is also reported as an independent risk factor for the severity of COVID-19 3,4 . We have previously reported that the association of hypertension, diabetes, and ethnicities, all of which that correlate to obesity, with the severity of COVID-19 and H1N1 may be confounded by obesity to a considerable extent 5 . Hyperuricemia and obesity are known to be significantly correlated. Although multiple regression analysis showed that hyperuricemia is an independent risk factor for COVID-related death, the analysis did not include obesity or body mass index as an explanatory variable. Therefore, to truly show that hyperuricemia is a novel risk factor for COVID-related death, a multiple regression analysis including obesity as an explanatory variable is warranted. Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study Why obesity, hypertension, diabetes, and ethnicities are common risk factors for COVID-19 and H1N1 influenza infections